Free Novo Nordisk diabetes meds for income-qualified patients. ≤400% FPL for most products; ≤200% FPL for Ozempic (uninsured).
Doctor signature neededUninsured only
What you need to enroll
Your doctor needs to sign part of the application
This program requires a prescriber signature. The easiest path: download the application, bring it to your next appointment, and have the office fax it in for you.
Your copay
Free
Eligible patients pay $0. See the eligibility checklist below to confirm you qualify.
NovoFine 32G needles (100/box) — only for FlexPen / FlexTouch / Xultophy users
Am I eligible?
Need a prescription?
Yes — written by a licensed prescriber for the medications below.
Insurance required?
Uninsured patients only — not for anyone with insurance.
State restrictions?
Available nationwide.
Income limits?
Yes — household income limits apply. Verify with the program.
Who qualifies
US resident
Household income ≤ 400% FPL (≤200% FPL for Ozempic uninsured)
Uninsured OR Medicare Part D (excluding Ozempic 2026 onward)
Not enrolled in Medicaid, LIS/Extra Help, or VA Benefits
Has a Novo Nordisk Rx and an HCP signature on the application
Accepted
US resident, age 18+
Household income at or below 400% FPL (≤200% FPL for Ozempic uninsured)
Uninsured, or Medicare Part D (Medicare Part D NOT eligible for Ozempic as of 2026)
Has a current Novo Nordisk Rx
Not accepted
Commercial insurance with adequate Novo Nordisk drug coverage
Households above the applicable FPL limit
Enrolled in or eligible for Medicaid, Medicare LIS / Extra Help, or VA Benefits
Medicare Part D beneficiaries seeking Ozempic (2026 exclusion)
Wegovy, Rybelsus, and Victoza (not on the 2026 PAP product list)
Non–Novo Nordisk medications
How to apply
Visit diabetespap.novocare.com and submit the patient portion online
Provide your healthcare provider's email — they'll receive a secure link to complete their portion
If prompted, upload supporting docs: Proof of Income, Medicaid LIS Denial, Government ID
If approved, Neovance Specialty Pharmacy (1-800-488-5908) will call to schedule home delivery
Program contact: 1-866-310-7549
Using it at the pharmacy
This is patient assistance — Novo Nordisk's Neovance Specialty Pharmacy (1-800-488-5908) ships the medication directly to the patient's home. No pharmacy handoff once approved.
Income tiers by product/insurance: (1) Most Novo Nordisk products: ≤400% FPL. (2) Ozempic UNINSURED: ≤200% FPL only. (3) Ozempic Medicare Part D: NOT ELIGIBLE — Medicare patients should use the Medicare Prescription Payment Plan (MPPP) instead. (4) Medicare patients on Novo Nordisk INSULINS: ≤400% FPL, but if income is below 150% FPL you must provide proof of denial for Part D Extra Help. Uninsured patients in states with high FPL thresholds must provide proof of Medicaid denial before enrollment. Wegovy, Rybelsus, and Victoza are NOT covered by the PAP. Levemir was discontinued by Novo Nordisk in the US on Dec 31, 2024 and is no longer in the PAP. Document ID NNIPAP_11_01012026.
Be first when we launch — we'll save these matches and remind you to renew.